New injection aims to restore strength in seniors with sarcopenia

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects aged ≥ 65 years (for female subjects, those who are medically unable to become pregnant) * Subjects diagnosed with sarcopenia in accordance with the Korean Working Group on Sarcopenia (KWGS) guidelines * Subjects with a body weight of ≥ 35 kg and a body mass index (BMI) of ≥ 15 kg/m² and \< 30 kg/m² * Subjects with a nutritional status screening score of ≥ 8 as assessed by the Mini Nutritional Assessment (MNA) questionnaire Exclusion Criteria: * Subjects with a history of diseases or surgical procedures that may affect physical activity or function * Subjects with underlying muscle disorders, including myopathy or muscular atrophy * Subjects with neuromuscular or neurological disorders * Subjects with uncontrolled diabetes mellitus, severe renal impairment, uncontrolled thyroid disorders, vitamin D deficiency, severe hepatic impairment, severe cardiac disease, uncontrolled hypertension, respiratory disorders * Subjects with clinically significant findings on a 12-lead electrocardiogram (ECG) * Subjects who are positive for active hepatitis B, active hepatitis C, syphilis, or human immunodeficiency virus * Subjects with a history of malignancy within 5 years * Subjects who have received systemic immunosuppressants or immunostimulants * Subjects who have undergone treatment with plasmapheresis within 8 weeks * Subjects who have received treatment with medications prohibited in this clinical trial within 4 weeks * Subjects with hemoglobin levels \< 10 g/dL * Subjects who have undergone surgery requiring general anesthesia within 4 weeks * Subjects who are unable to walk or are physically inactive * Subjects who are participating in or planning to participate in a separate high-intensity program for increasing muscle mass or strength during the clinical trial period * Subjects with severe psychiatric disorders such as major depression, schizophrenia, alcoholism, or drug dependence * Subjects with a score of \< 24 on the Korean version of the Mini Mental State Examination (MMSE-K) * Subjects with known allergies or hypersensitivity to the investigational product or its excipients